Pliant Therapeutics (PLRX) Other Working Capital Changes (2021 - 2026)
Pliant Therapeutics (PLRX) posted quarterly Other Working Capital Changes of -$320000.0 for Q1 2026, down 251.65% year-over-year from $211014.5 in Q1 2025, and down 2.24% quarter-over-quarter from -$313000.0 in Q4 2025.
Pliant Therapeutics (PLRX) Other Working Capital Changes (2021 - 2026) Analysis & Trends
Pliant Therapeutics (PLRX) has reported Other Working Capital Changes for 6 consecutive years, with -$320000.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Other Working Capital Changes fell 251.65% year-over-year to -$320000.0; the TTM figure through Mar 2026 stood at -$1.1 million (down 101.64% YoY), while the FY2025 annual figure was -$876000.0, down 6.83% from the prior year.
- Other Working Capital Changes eased to -$320000.0 in Q1 2026 per PLRX's latest filing, from -$313000.0 in the prior quarter.
- Across five years, Other Working Capital Changes topped out at $3.4 million in Q2 2024 and bottomed at -$5.4 million in Q3 2024.
- Historically, Other Working Capital Changes has averaged -$291352.9 across 5 years, with a median of -$698000.0 in 2022.
- On a YoY basis, Other Working Capital Changes climbed as much as 144.68% in 2025 and fell as far as 629.27% in 2025.
- Pliant Therapeutics' Other Working Capital Changes stood at -$889000.0 in 2022, then grew by 16.42% to -$743000.0 in 2023, then soared by 87.48% to -$93000.0 in 2024, then slumped by 236.56% to -$313000.0 in 2025, then slipped by 2.24% to -$320000.0 in 2026.
- Business Quant data shows PLRX's Other Working Capital Changes at -$320000.0 in Q1 2026, -$313000.0 in Q4 2025, and -$598000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.84 Bn | 131.99 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 86.48 Bn | 78.49 Bn | 3.93 Bn |
| 3 | Argenx Se | 65.47 Bn | 60.29 Bn | 1.37 Bn |
| 4 | Moderna | 60.15 Bn | 55.01 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 42.22 Bn | 37.12 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.67 Bn | 28.36 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.54 Bn | 10.14 Bn | 668.28 Mn |
| 8 | Insmed | 27.58 Bn | 26.42 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.22 Bn | 26.38 Bn | - |
| 10 | Pliant Therapeutics | 71.52 Mn | 71.52 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -42,000.00 |
| Jun 30, 2026 | -42,000.00 |
| Jun 30, 2026 | -42,000.00 |
| Mar 31, 2026 | -320,000.00 |
| Mar 31, 2026 | -320,000.00 |
| Mar 31, 2026 | -320,000.00 |
| Dec 31, 2025 | -313,000.00 |
| Dec 31, 2025 | -313,000.00 |
| Dec 31, 2025 | -313,000.00 |
| Sep 30, 2025 | -598,000.00 |
| Sep 30, 2025 | -598,000.00 |
| Sep 30, 2025 | -598,000.00 |
| Jun 30, 2025 | 126,000.00 |
| Jun 30, 2025 | 126,000.00 |
| Jun 30, 2025 | 126,000.00 |
| Mar 31, 2025 | -91,000.00 |
| Mar 31, 2025 | -91,000.00 |
| Mar 31, 2025 | -91,000.00 |
| Dec 31, 2024 | -93,000.00 |
| Dec 31, 2024 | -93,000.00 |